eScholarship
metadata only
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
OBJECTIVE: Blood-based biomarkers for neurodegenerative conditions could improve diagnosis and treatment development. Neurofilament light chain (NfL), a marker of axonal injury, is elevated in cerebrospinal fluid (CSF) of patients with progressive supranuclear palsy (PSP). The goal of this study was
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases#384809
- Synapse loss in Progressive Supranuclear Palsy post-mortem reflects clinical and pathological disease severity and 11C-UCB-J PET in vivo#349768
- Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy#874104
- Longitudinal cognitive outcomes in two progressive supranuclear palsy clinical trials.#320397
- Geschichte der Neurologie und berühmte Patienten mit neurologischen Erkrankungen / by: Limmroth, Volker#1353723
Record · ID 1250227
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive